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Summary 
Because phosphatidic acid (PA) pathway signaling may mediate many basic reactions involving 
cytokine-dependent responses, we investigated the effects of CT1501R, a functional inhibitor 
of the enzyme lysophosphatidic acid acyhransferase (LPAAT) which converts lysophosphatidic 
acid (Lyso-PA) to PA. We found that CT1501R treatment not only prevented hypoxia-induced 
PA increases and lyso-PA consumption in human neutrophils, but also prevented neutrophil 
chemotaxis and adherence in vitro, and lung injury and lung neutrophil accumulation in mice 
subjected to hemorrhage and resuscitation. In addition, CT1501R treatment prevented increases 
in mRNA levels and protein production of a variety of proinflammatory cytokines in multiple 
lung cell populations after blood loss and resuscitation. Our results  indicate the fundamental 
role of PA metabolism in the development of acute inflammatory lung injury after blood loss. 
~  ute edematous lung injury (ARDS) 1 is a highly fatal 
(mortality >50%) disorder, characterized  by increased 
lung cytokine levels and massive neutrophil accumulation in 
the lung (1). Blood loss, such as occurs after severe injury, 
even if resuscitated,  is associated with increased expression 
of proinflammatory cytokines, such as TNF-ol and IL-1/~, and 
the frequent development of acute lung injury (2-5). Although 
ARDS often occurs after an ischemia (hypoxia)-reperfusion 
(reoxygenation) insult caused by hemorrhage and resuscita- 
tion, the relationship between hypoxia, cytokine activation, 
neutrophil recruitment, and lung injury is unknown. 
Certain species of PA that do not contain arachidonate in 
either the sn-1 or sn-2 positions are produced from lyso-PA 
by the membrane associated enzyme, lysophosphatidic acid 
acyl transferase (LPAAT). Each system in which PA formation 
via LPAAT has previously been demonstrated (i.e., IL-lfl, lipid 
A or hydrophobic chemotherapeutic compounds) either in- 
volves activation of phospholipase A2, or causes membrane 
perturbation or release of reactive oxygen intermediates which 
indirectly activate phospholipase A2 (6,  7). These PA spe- 
cies are then rapidly converted to 1,2 diacylglycerol (DAG) 
by phosphatidate phosphohydrolase (PAPH) (7-9). Both PA 
1  Abbreviations used in this  paper: AM, alveolar  macrophages; ARDS, acute 
edematous lung injury; IPMC, intraparenchymal  pulmonary mononuclear 
cells; LPAAT,  lysophosphatidic  acid acyltransferase;  lyso-PA,  lysophospha- 
tidic acid; PA, phosphatidic acid. 
and DAG function as intracellular second messengers and can 
be distinguished from the end-products of the phosphatidyl 
inositol pathway by the absence of sn-2 arachidonate (7, 8). 
CT1501R, 1-(5-R-hydroxyhexyl)-3,7-dimethyl xanthine, is 
a functional inhibitor of LPAAT activity which reduces specific 
PA generation (8). For example,  CT1501R suppresses the 
generation of PA induced by bacterial lipopolysaccharide with 
an IC50 of 0.5-0.6/zM in the murine monocytic leukemia 
cell line, P388, in vitro (8). Adding CT1501R to lipopolysac- 
charide-stimulated blood mononuclear cells inhibited TNF-o6 
IL-1B and I1.-6 release, as well as IL-1/~ and TNF-c~ mRNA 
accumulation, without affecting IL-8 expression (10). Simi- 
larly, inhibiting PA formation with CT-1501R protected mice 
from endotoxin lethality (8). Because of the apparent role 
of PA as an intracellular second messenger in neutrophil acti- 
vation (11) and cytokine dependent responses, we investigated 
the effects of inhibiting PA generation on neutrophil func- 
tion in vitro as well as cytokine expression and the develop- 
ment of acute lung injury after hemorrhage and resuscita- 
tion in vivo. 
Materials and Methods 
Human Neutrophil Isolation.  Human neutrophils (PMN) were 
prepared from heparinized blood obtained from consenting, healthy 
human volunteers. Neutrophils were isolated and highly purified 
(>99%) by Percoll  gradient  and differential centrifugation and 
resuspended in HBSS. 
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placed in hypoxia (95% N2  +  5% CO2) and then reoxygenated 
(21% 02  +  5% CO2). After neutrophils were fixed in ice-cold 
methanol, lipids were extracted and separated by HPLC with a 
Waters #-Poracil  |  silica  column, using an anisocratic  gradient (7-9). 
Lipids  in the column effluent  were monitored at 206-224 nm. HPLC 
fractions were also analyzed by thin layer chromatography, amine 
content, acyl  content, and mass spectrometry to confirm peak iden- 
tities. Fast-atom bombardment mass spectrometry spectra were ac- 
quired using a VG 70 SEQ tandem hybrid instrument  of EBqQ 
geometry (VG Analytical, Altrincham, UK) as previously  described 
(7, 8). Mass of total PA varied from 0.65-0.75%  in unstimulated 
neutrophils, to 2.7-3.6%  of total detectable lipids in stimulated 
neutrophils (increased  by 3.5-5-fold); lyso-PA  mass in neutrophils 
pretreated with CT1501R and subjected to hypoxia-reoxygenation 
could range as high as 7-8% of total detectable lipids. 
Neutrophil Function  Studies.  Neutrophil chemotactic  activity  was 
determined by Boyden  chamber assay  and quantitated as the number 
of migrating PMN/5HPF using zymosan-activated serum as the 
chemoattractant (12). Neutrophil adherence was assessed  by quan- 
titating the percentage of neutrophils adhering to nylon fibers after 
addition of phorbol myristate acetate (PMA 10 -6 M; Sigma Chem. 
Co., St. Louis, MO) (13). Neutrophil superoxide production was 
determined by quantitating superoxide dismutase  inhibitable  reduc- 
tion of cytochrome c in response to PMA (10 -6 M) (14). 
Hemorrhage and Resuscitation Evaluation. After methoxyflurane 
anesthesia, male  BALB/c mice  (Harlan-Sprague-Dawley, Indi- 
anapolis, IN) 8-14 wk old, had 30% of  their calculated  blood volume 
(,o0.55 ml for a 20-gm mouse) withdrawn via cardiac puncture 
over 60 s (2, 15). Blood was collected in a heparinized (5 U) sy- 
tinge, kept at 37~  for 1 h, and then reinfused into the retroor- 
bital plexus of the briefly (<1 min) reanesthetized mouse. Resusci- 
tated survivors did not develop hemothorax,  bleeding into the 
pericardial space, lung or cardiac contusion. Control mice were 
subjected similarly  to anesthesia  and cardiac  puncture without blood 
withdrawal, and then injected retroorbitally with heparin (5 U) 
in 0.2 ml PBS. 
Semiquantitative PCR Analysis of Cytokine mRNA Levels.  Rel- 
ative cytokine mRNA levels were determined by semiquantitative 
PCR on alveolar macrophages (AM), peripheral blood monocytes 
(PBMC),  and  intraparenchymal pulmonary  mononuclear cells 
(IPMC) collected from mice 3 d after hemorrhage-resuscitation 
(2, 4). AM were isolated by centrifugation of bronchoalveolar la- 
,cage (BAL) obtained by injecting and then aspirating 1.0 ml PBS 
intratracheaUy. PBMC were isolated  from heparinized  blood diluted 
2:1 with PBS, pH 7.3, and layered  onto a lympholyte-m gradient. 
After centrifugation at 600 g for 20 min at 15~  cells at the inter- 
face were collected, washed in RPMI 1640, counted, and assessed 
for viability which was consistently greater than 98% by trypan 
blue exclusion. IPMC were isolated by collagenase digestion and 
Percoll gradient purification (16). mRNA was extracted from iso- 
lated cells using oligo dT columns (Micro-FastTrack; Invitrogen, 
San Diego, CA). cDNA was then synthesized from the mRNA 
of 20,000 AM, 100,000 PBMC, or 100,000 IPMC using Maloney 
murine leukemia virus reverse transcriptase and random hexamer 
oligonucleotides (2, 17). After a 2-rain, 94~  denaturation step, 
between 34 and 38 cycles of PCR were conducted (45 s, 94~ 
denaturation; 45 s, 60~  annealing; and 2 min, 72~  extension) 
on cDNA from 1000 AM, 10,000 IPMC, or 10,000 PBMC. All 
cDNA samples were mixed with aliquots of the same PCR master 
mix using appropriate cytokine  MIMICs (Clontech, Palo Alto, CA) 
as internal controls for standardization of PCR product (2,  18). 
Cytokine  primers (Clontech) were used at 0.4 #M.  To detect 
amplified cDNA, the PCR product was analyzed by agarose gel 
electrophoresis. The number of PCR cycles  were selected for the 
cytokine  product from each cellular  population so that the ethidium 
bromide stained amplified  DNA products were between barely de- 
tectable and below saturation. The gel was then captured for com- 
puter integration using a UVP System (UVP Inc., San Gabriel, 
CA). Densitometry  results  were normalized  to those for the cytokine 
MIMIC. 
ELISA Assay  for Cytokines.  After centrifugation, supernatants 
from BAL were stored at  -70~  ELISA for TNF-o~ and IFN-y 
content in BAL supernatants used paired monoclonal anti-mouse 
TNF-c~ (MP6-XT3 and biotinylated MP6-XT22) and IFN-3, (R4- 
6A2 and biotinylated  XMG1.2) antibodies (PharMingen, San Diego, 
CA), and alkaline phosphatase-conjugated strepavidin (Southern 
Biotechnology,  Birmingham,  AL), with recombinant  mouse  TNF-ot 
and IFN-~ as standards. The sensitivity  of the ELISA  was 10 pg/ml. 
Histologic Analyses.  At 3 d after hemorrhage-resuscitation,  mice 
were killed and the pulmonary circulation flushed  by injecting PBS 
into the right ventricle. Lungs were formalin injected through the 
trachea, then removed en bloc with the heart and placed into for- 
malin. Hematoxylin and eosin sections were prepared and exam- 
ined blindly by a pulmonary pathologist (RT). Grading of the his- 
topathologic changes (HE stain x  92 magnification) in the lungs 
(neutrophil infiltration, interstitial edema, and intraalveolar  hemor- 
rhage) was performed on a 0 to 3 scale (with 0 being normal and 
3 being the most severe abnormality). 
StatisticaIAnalyses.  Data are presented  as mean _+ SEM. Groups 
were compared using one way analysis of variance and either the 
Student-Newman-Keuls or the Tukey-Kramer  Multiple Compar- 
ison tests for differences  between groups. A p value of <0.05 was 
considered to be statistically significant. 
Results and Discussion 
To test the inhibition of LPAAT by CT1501R, we exposed 
CT1501R-treated human neutrophils to hypoxia and then re- 
oxygenation in vitro. After exposure to hypoxia for 60 min 
and then reoxygenation for 20 min, human neutrophils had 
increased PA concentrations with a retention time (ILl) char- 
acteristic of linoleate~enriched PA species (Fig. 1). Hypoxia-re- 
oxygenated neutrophils preincubated with 10-100 #M CT- 
1501R had decreased PA (Fig. 2 a) and increased lyso-PA (Fig. 
2  b)  concentrations  compared  to  untreated  neutrophils. 
CT1501R treatment also reduced stimulated human neutro- 
phil adherence (Fig. 3 a) and chemotaxis (Fig. 3 b), but not 
neutrophil superoxide anion generation (Hg. 3 c), in vitro. 
Severe hemorrhage causes  a  systemic hypoxia and then 
replacement of blood reoxygenates ischemic tissues (19). A 
frequent consequence of these events is the development of 
ARDS which appears to derive from an oxidative insult in- 
volving neutrophils and/or xanthine oxidase (1). Because our 
findings indicated that CT1501R treatment not only inhibited 
the generation of PA species during hypoxia-reoxygenation 
but also neutrophil function in vitro, we suspected that PA 
participates  in  inflammatory  lung  injury  after  hemor- 
rhage-resuscitation. Mice treated 1 h after severe hemorrhage 
with CT-1501R  given along with the previously removed 
blood during the resuscitation phase had decreased (p <0.05) 
interstitial lung edema (Fig.  4 a)  and intraalveolar hemor- 
rhage (Fig. 4 b) compared to untreated mice. Moreover, after 
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Figure  1.  Effect  of hypoxia reoxygenation on neutrophil PA metabo- 
lism. Representative experimental HPLC tracings for untreated,  control 
neutrophils (a), untreated neutrophils exposed to hypoxic conditions for 
60 min and then reoxygenation for 20 min (b), and neutrophils incubated 
with 10 #M CT1501R, then exposed to hypoxia-reoxygenation (c). Con- 
trol neutrophils synthesized little PA or lyso-PA, whereas untreated, hyp- 
oxia-reoxygenated neutrophils synthesized a variety of PA species, partic- 
ularly Rs  min PA. In contrast to PA, neutrophils treated with CT1501R 
accumulated lyso-PA species, with attenuation in synthesis of PA species, 
particularly Rf 4-8 min. Consistent with published results (9), phosphatidyl 
inositol (PI) mass was diminished by hypoxia-reoxygenation (b), and this 
process was not inhibited by adding CT1501R  (c). 
hemorrhage, mice resuscitated  with CT1501R  had fewer 
(p <0.05) pulmonary interstitial  neutrophils than untreated 
mice (Fig. 4 c) and the percentage of BAL leukocytes that 
were neutrophils in lungs of CT1501R  treated  mice (6  -+ 
2%) was less (v <0.05) than the percentage of neutrophils 
in untreated mice (14  _+  2%).  The decreased injury and 
inflammation in lungs of CT1501R  treated  mice was cor- 
roborated  by histological  analysis (Fig.  5). 
For unknown reasons, increased lung cytokine levels are 
a prominent feature in patients with ARDS and in mice sub- 
jected to hemorrhage-resuscitation (2, 4, 20, 21). We found 
that alveolar macrophages (Fig. 6 a), blood monocytes (Fig. 
6 b) and intraparenchymal  lung mononuclear cells (Fig. 6 c) 
from hemorrhaged mice resuscitated with CT1501R had de- 
creased (p <0.05) mRNA levels for TNF-ot compared to un- 
treated,  hemorrhaged and resuscitated mice. Similarly, in- 
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Figure 2.  Effect  of hypoxia-reoxygenation  on neutrophil PA metabo- 
lism. CT1501R  treatment inhibited PA increases and lyso-PA decreases 
in human neutrophils subjected to hypoxia-reoxygenation in vitro. (a) After 
hypoxia-reoxygenation,  untreated neutrophils had a rapid rise in Rf 4-8 
min PA (enriched in sn-2 linoleoyl moieties and sn-1 acyl C18 saturated 
and unsaturated moieties) and essentially a partially sustained or oscilla- 
tory production of PA. Adding 10 or 100/~M CT1501R to neutrophils 
at the onset of hypoxia blunted PA production. (b) Hypoxia-reoxygenated, 
untreated neutrophils had little Rf 2-3 min lyso-PA (enriched in sn-1 acyl 
C18 saturated and unsaturated moieties), whereas CT1501R treated neu- 
trophils accumulated lyso-PA. Lipid masses are determined by absorption 
at 217-222 nm, and then normalized to total mass. The masses shown 
are averaged from five experiments where each time point was performed 
in triplicate, with error bars showing SEM. 
traparenchymal lung mononudear cells from hemorrhaged 
mice resuscitated with CT1501R  had decreased ~  <0.05) 
amounts of mRNA for IL-13 (Fig. 6 d), IL-6 (Fig. 6 e), and 
IFN-  7 (Fig. 6 f) compared to untreated, hemorrhaged and 
resuscitated controls. In paraUel, BAL recovered from hemor- 
rhaged and CT1501R  resuscitated mice had less ~  <0.05) 
TNF-o~ (Fig. 6 g) and IFN-7 (Fig. 6 h) activity than BAL 
from untreated, hemorrhaged, and resuscitated mice. Thus, 
resuscitation with CT1501R after hemorrhage decreased the 
expression and activity of a number of different cytokines 
in circulating mononuclear cells and resident  lung cells. 
Our results  show that PA may fundamentally mediate 
multiple events responsible for the development of acute lung 
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Figure 3.  Effect of LPAAT inhibition of neutrophil function in vitro. 
Adding CT1501R (7/zM) decreased (p <0.05)  stimulated human neutro- 
phil adherence (a) and chemotaxis (b), but not superoxide anion generation 
(c), in vitro. Each value is the mean  _+  SE of six or more determinations 
compared by analysis of variance and corrected by Student-Newman-Keuls 
test for differences between groups using a/~ value of <0.05 as significant. 
injury after hemorrhage and resuscitation.  CT1501R  treat- 
ment after blood loss decreased lung injury and lung neutro- 
phil accumulation in mice subjected to hemorrhage-resuscita- 
tion- a finding paralleled by CT1501R treatment decreasing 
neutrophil function in vitro.  Our results also suggest that 
systemic hypoxia followed by tissue reoxygenation,  such as 
occurs in hemorrhage-resuscitation, induces the formation 
of PA in neutrophils as well as in lung tissue. Increased pro- 
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Effect of LPAAT inhibition of lung injury in mice subjected  Figure  4. 
to hemorrhage and resuscitation.  Hemorrhaged mice treated  with CT- 
1501R during resuscitation had reduced (p <0.05) interstitial lung edema 
(a), intraalveolar hemorrhage (b), and neutrophil accumulation  (c), com- 
pared to untreated mice subjected to hemorrhage-resuscitation.  Treatment 
with CT 1501R (tOO mg/kg given in 0.2 ml PBS) or 0.2 ml PBS i.v. was 
started 1 h after hemorrhage or cardiac puncture,  and then was given i.p. 
every 8 h for a total of 9 doses over 72 h. Each mean  +_  SE for 6-8 mice 
was analyzed by one way analysis of variance with the Tukey-Kramer mul- 
tiple comparison  test using  a p value of <0.05  as significant. 
duction of PA then induces neutrophil chemotaxis, proinflam- 
matory cytokine generation and lung injury. Although the 
present experiments revealed that inhibition of LPAAT with 
CT1501R decreased in vitro neutrophil chemotaxis and ad- 
herence induced by zymosan and PMA, additional  studies 
will be necessary to determine whether inhibition of neutro- 
phil functions occurs when other signaling pathways are ac- 
tivated, particularly  in the in vivo setting. 
CT1501R also abrogated the induction of mRNA for sev- 
eral proinflammatory cytokines in multiple cell types in the 
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Figure  5.  Effect  of LPAAT inhibition on lung histology  in mice subjected  to hemorrhage and resuscitation. Lungs from hemorrhaged mice treated 
with CT1501R  during resuscitation  had reduced  histologic  abnormalities compared  to lungs from untreated mice subjected  to hemorrhage-resuscitation. 
Representative hematoxylin and eosin stained pulmonary sections obtained 3 d after cardiac puncture in mice subjected  to methoxyflurane anesthesia 
and cardiac puncture, without blood withdrawal, followed 1 h later by retroorbital injection of 5 U heparin in 0.1 ml PBS (Control), in mice subjected 
to 30% blood volume hemorrhage and then resuscitated with the shed blood 1 h after (Hemorrhage)  and in mice subjected to 30% blood volume 
hemorrhage and then resuscitated with the shed blood 1 h later, but treated with CT1501R. every 8 h starting 1 h after hemorrhage (Hemorrhage 
+  CT1501K). The pulmonary histology in control mice is not different from that seen in normal, unmanipulated and unhemorrhaged mice. 
lungs of mice subjected to hemorrhage-resuscitation.  The 
protean effects and extensive protection which occurred after 
CT1501K treatment is most likely explained by the basic sig- 
naling nature of PA on diverse components of the inflamma- 
tory cascade. Inflammatory stimuli translocate LPAAT to the 
plasma membrane (7); therefore, it is possible that transloca- 
tion and activation of LPAAT also occurs after oxidative stress. 
PA produced by LPAAT may also directly activate atypical 
protein kinase C  species or alternative kinases and may alter 
GTPase activating protein/ras  interactions  (22-24).  Adding 
PA to cells also produces potent mitogenic effects, stimulates 
calcium flux and phospholipase C  activity, and induces ex- 
pression of several protooncogenes and growth factors (25-27). 
At our dose of CT1501R,  inhibition  of LPAAT appears to 
be the primary  intracellular  signaling  pathway responsible 
for the observed effects on neutrophil function and lung in- 
jury, although it is possible that diacylglycerols formed from 
PA by phosphatidate phosphohydrolase rather than PA itself 
are  the relevant  signaling  molecules affected by CT1501R. 
The  ICs0 for inhibiting  phosphodiesterase by CT1501R is 
between 100 and 500 #M in vitro systems,  significantly above 
concentrations  (i.e.,  10-30 #M)  at  which  CT1501K effec- 
tively inhibits  PA synthesis (6,  8).  It is notable that  PI hy- 
drolysis and DG/IP3  formation,  as well as Ca +z flux,  are 
not inhibited by CT1501R (8). Similarly, sphingomyelin hy- 
drolysis to ceramide and TNF-ot induced apoptosis via NF-kB 
are not  inhibited  by CT1501R  (28). 
Lyso-PA is a potent mitogenic stimulus through ras/MAPK 
and rho activation via an external receptor which functions 
to activate G proteins (29). However, intracellular  injection 
of lyso-PA appears to lack the activating effects induced by 
interactions  of lyso-PA with its external receptor (7, 30). There- 
fore, it is unlikely that intracellular  accumulation of lyso-PA 
through LPAAT inhibition by CT1501K plays an important 
counter-regulatory  role in intracellular  signaling. 
Our findings suggest that inhibiting PA may have poten- 
tial in the treatment  and prevention  of conditions,  such as 
ARDS and septic shock,  which are associated with activa- 
tion of a proinflammatory cytokine cascade (2, 8, 10, 20, 21, 
31). Because PA proximally mediates a basic intracellular sig- 
naling mechanism, inhibiting PA with CT1501R may be more 
effective therapeutically  than  agents  which have more dis- 
crete effects. For example, the interleukin-1  receptor antagonist 
decreases only II,-1 effects and has no direct effect on neutro- 
phil  function  in vitro  (32). 
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Figure 6.  Effect  of LPAAT  in- 
hibition on lung cytokines  in mice 
subjected  to  hemorrhage  and 
resuscitation. Hemorrhaged mice 
which  were  resuscitated  with 
CT1501R had decreased (p <0.05) 
amounts of mRNA for TNF-~ in 
their alveolar  macrophages (a) and 
blood mononuclear cells (b), de- 
creased mRNA levels for TNF-a 
(c), IL-1/~  (d), Ir-6 (e), and IFN-'y 
(f) in their intraparenchymal  lung 
mononuclear cells, and decreased 
TNF-ct (g) and IFN-'y (h) activity 
in  their bronchoalveolar  lavage 
(BAL) compared to untreated hem- 
orrhaged-resuscitated mice. The 
mean _+ SE for 6-8 mice was ana- 
lyzed by one way analysis of vari- 
ance with the Tukey-Kramer  mul- 
tiple  comparison  test  using p 
(0.05 as significant. 
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